We are live on ! Find out more
LCM

Logan Capital Management Portfolio holdings

AUM $2.3B
1-Year Est. Return 30.85%
This Fund
S&P 500
This Quarter Est. Return
+14.43%
1 Year Est. Return
+30.85%
3 Year Est. Return
+98.58%
5 Year Est. Return
+129.12%
10 Year Est. Return
+659.24%
AUM
$2.15B
AUM Growth
-$49.6M
Cap. Flow
-$257M
Cap. Flow %
-11.96%
Top 10 Hldgs %
31.81%
Holding
581
New
5
Increased
46
Reduced
242
Closed
89

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$2.97M
2
MSI icon
Motorola Solutions
MSI
+$1.93M
3
BRO icon
Brown & Brown
BRO
+$1.9M
4
SNY icon
Sanofi
SNY
+$1.45M
5
DEO icon
Diageo
DEO
+$1.01M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$14.1M
2
AVGO icon
Broadcom
AVGO
+$11.1M
3
LCLG icon
Logan Capital Broad Innovative Growth ETF
LCLG
+$8.65M
4
AMZN icon
Amazon
AMZN
+$7.38M
5
PM icon
Philip Morris
PM
+$7.17M

Sector Composition

Rank Sector Weight
1 Technology 29%
2 Consumer Discretionary 12.99%
3 Industrials 12.33%
4 Communication Services 11.76%
5 Financials 11.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPHQ icon
426
Invesco S&P 500 Quality ETF
SPHQ
$19.7B
$999 ﹤0.01%
14
KDP icon
427
Keurig Dr Pepper
KDP
$41.3B
$926 ﹤0.01%
28
IWR icon
428
iShares Russell Mid-Cap ETF
IWR
$56.7B
$920 ﹤0.01%
10
WTW icon
429
Willis Towers Watson
WTW
$31.6B
$920 ﹤0.01%
3
ICE icon
430
Intercontinental Exchange
ICE
$84.1B
$917 ﹤0.01%
5
AMAT icon
431
Applied Materials
AMAT
$419B
$915 ﹤0.01%
5
DGX icon
432
Quest Diagnostics
DGX
$26.3B
$898 ﹤0.01%
5
-4
-44% -$695
VRTX icon
433
Vertex Pharmaceuticals
VRTX
$123B
$890 ﹤0.01%
2
MRSH
434
Marsh
MRSH
$92.2B
$875 ﹤0.01%
4
-298
-99% -$67.3K
XLB icon
435
State Street Materials Select Sector SPDR ETF
XLB
$8.55B
$818 ﹤0.01%
18
AMG icon
436
Affiliated Managers Group
AMG
$9.83B
$787 ﹤0.01%
4
EFX icon
437
Equifax
EFX
$20.7B
$778 ﹤0.01%
3
YUM icon
438
Yum! Brands
YUM
$41.6B
$741 ﹤0.01%
5
-295
-98% -$43.1K
MU icon
439
Micron Technology
MU
$996B
$740 ﹤0.01%
6
DOX icon
440
Amdocs
DOX
$6.28B
$730 ﹤0.01%
8
-768
-99% -$68.7K
GS icon
441
Goldman Sachs
GS
$301B
$708 ﹤0.01%
1
FCX icon
442
Freeport-McMoran
FCX
$95.5B
$694 ﹤0.01%
16
CAH icon
443
Cardinal Health
CAH
$55.7B
$672 ﹤0.01%
4
ALNY icon
444
Alnylam Pharmaceuticals
ALNY
$28.9B
$652 ﹤0.01%
2
CCEP icon
445
Coca-Cola Europacific Partners
CCEP
$47.9B
$649 ﹤0.01%
7
GEN icon
446
Gen Digital
GEN
$16.8B
$647 ﹤0.01%
22
ITT icon
447
ITT
ITT
$19.2B
$627 ﹤0.01%
4
PNR icon
448
Pentair
PNR
$11.2B
$616 ﹤0.01%
6
IUSG icon
449
iShares Core S&P US Growth ETF
IUSG
$33.4B
$602 ﹤0.01%
4
CVE icon
450
Cenovus Energy
CVE
$52.1B
$585 ﹤0.01%
43

Similar funds

Logan Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Logan Capital Management held 581 positions worth $2.15B, down 2.3% from $2.2B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Logan Capital Management withdrew a net $257M in Q2 2025, closing 89 positions and reducing 242 holdings. Its most notable exit was Vanguard S&P 500 Value ETF, an estimated $1.26M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Logan Capital Management opened a new position in JPMorgan International Research Enhanced Equity ETF worth $26.2K.

  • Logan Capital Management's largest Q2 2025 buy was JPMorgan International Research Enhanced Equity ETF: 370 shares worth $26.2K.
  • Logan Capital Management added most to TJX Companies in Q2 2025, an estimated $2.97M increase.
  • Logan Capital Management's biggest Q2 2025 reduction was Apple, cutting an estimated $14.1M.
  • Logan Capital Management fully exited Vanguard S&P 500 Value ETF in Q2 2025, selling an estimated $1.26M.
  • Logan Capital Management's ten largest holdings make up 32% of its $2.15B portfolio in Q2 2025.
  • Logan Capital Management opened 5 new positions and closed 89 in Q2 2025.
  • Logan Capital Management's portfolio value fell 2.3% quarter-over-quarter to $2.15B.

Based on Logan Capital Management's 13F filing for Q2 2025, filed 1 Aug 2025.